672 related articles for article (PubMed ID: 23970420)
1. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
3. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
[TBL] [Abstract][Full Text] [Related]
4. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
Zheng J; Dong P; Gao S; Wang N; Yu F
Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
[TBL] [Abstract][Full Text] [Related]
5. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
6. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Tanaka K; Miyata H; Yamasaki M; Sugimura K; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S607-15. PubMed ID: 23838916
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer.
Wu P; Tang RN; Zou JH; Wang FC
Hepatogastroenterology; 2012 Oct; 59(119):2164-7. PubMed ID: 23178553
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
9. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.
Pu XX; Huang GL; Guo HQ; Guo CC; Li H; Ye S; Ling S; Jiang L; Tian Y; Lin TY
J Gastroenterol Hepatol; 2010 Oct; 25(10):1674-80. PubMed ID: 20880178
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of microRNA-93 downregulation in human colon cancer.
Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
17. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
18. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
[TBL] [Abstract][Full Text] [Related]
20. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
